SP1 and prostate cancer: But whereas mithramycin A and ellipticine target proteins SP1 and TOPIIB are responsible for latent genome replication in hematopoietic cells, knockdown of these proteins in prostate cancer cells did not mimic mithramycin A or ellipticine induced phenotypes (Fig. S7A–E).